STRIDEBIO Trademark

Trademark Overview

On Tuesday, March 15, 2016, a trademark application was filed for STRIDEBIO with the United States Patent and Trademark Office. The USPTO has given the STRIDEBIO trademark a serial number of 86940166. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 29, 2024. This trademark is owned by Stride Therapeutics, LLC. The STRIDEBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and design and development of novel gene therapy vectors and therapeutics derived therefrom for vascular and lung, eye, brain, liver, and muscle diseases and conditions and genetic diseases

General Information

Serial Number86940166
Word MarkSTRIDEBIO
Filing DateTuesday, March 15, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 29, 2024
Registration Number5470158
Registration DateTuesday, May 15, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Pseudo MarkSTRIDE BIO
Goods and ServicesScientific research and design and development of novel gene therapy vectors and therapeutics derived therefrom for vascular and lung, eye, brain, liver, and muscle diseases and conditions and genetic diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 29, 2024
Primary Code042
First Use Anywhere DateSaturday, April 30, 2016
First Use In Commerce DateSaturday, April 30, 2016

Trademark Owner History

Party NameSTRIDEBIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27701
Party NameSTRIDEBIO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27701
Party NameSTRIDEBIO, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDURHAM, NC 27701
Party NameSTRIDEBIO, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressDURHAM, NC 27701
Party NameStride Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHockessin, DE 19707

Trademark Events

Event DateEvent Description
Friday, March 18, 2016NEW APPLICATION ENTERED
Friday, March 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2016NOTICE OF PSEUDO MARK MAILED
Saturday, June 25, 2016ASSIGNED TO EXAMINER
Sunday, June 26, 2016NON-FINAL ACTION WRITTEN
Monday, June 27, 2016NON-FINAL ACTION MAILED
Tuesday, December 6, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 30, 2016ASSIGNED TO LIE
Thursday, January 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 13, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 1, 2017NOTICE OF PUBLICATION
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2017NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, September 19, 2017USE AMENDMENT FILED
Wednesday, September 27, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 3, 2017STATEMENT OF USE PROCESSING COMPLETE
Saturday, October 28, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, October 30, 2017NON-FINAL ACTION MAILED
Wednesday, March 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 12, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 13, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, May 15, 2018REGISTERED-PRINCIPAL REGISTER
Friday, August 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 15, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 29, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

stridebio diseases brain lung vascular liver muscle genetic conditions therefrom derived